Unique pharmacological properties of serotoninergic G-protein coupled receptors from cestodes by Camicia, Federico et al.
RESEARCH ARTICLE
Unique pharmacological properties of
serotoninergic G-protein coupled receptors
from cestodes
Federico Camicia1, Ana M. Celentano1,2, Malcolm E. Johns3, John D. Chan4,
Lucas Maldonado1, Hugo Vaca1, Nicola´s Di Siervi5, Laura Kamentezky1, Ana M. Gamo6,
Silvia Ortega-Gutierrez6, Mar Martin-Fontecha6, Carlos Davio5, Jonathan S. Marchant7*,
Mara C. Rosenzvit1*
1 Universidad de Buenos Aires, Consejo Nacional de Investigaciones Cientı´ficas y Te´cnicas, Instituto de
Investigaciones en Microbiologı´a y Parasitologı´a Me´dica (IMPAM-UBA-CONICET), Facultad de Medicina,
Buenos Aires, Argentina, 2 Universidad de Buenos Aires, Facultad de Medicina, Departamento de
Microbiologı´a, Parasitologı´a e Inmunologı´a, Paraguay, CABA, Argentina, 3 Department of Pharmacology,
University of Minnesota, Minneapolis, Minnesota, United States of America, 4 Department of Biomedical
Sciences, Iowa State University, Ames, Iowa, United States of America, 5 Universidad de Buenos Aires,
Consejo Nacional de Investigaciones Cientı´ficas y Te´cnicas, Instituto de Investigaciones Farmacolo´gicas
(ININFA-UBA-CONICET), Facultad de Farmacia y Bioquı´mica, Buenos Aires, Argentina, 6 Departamento de
Quı´mica Orga´nica I, Facultad de Ciencias Quı´micas, Universidad Complutense de Madrid, Madrid, Spain,
7 Department of Cell Biology, Neurobiology & Anatomy; Medical College of Wisconsin; Watertown Plank
Road; Milwaukee; WI; United States of America
* mrosenzvit@fmed.uba.ar (MCR); jmarchant@mcw.edu (JSM)
Abstract
Background
Cestodes are a diverse group of parasites, some of them being agents of neglected dis-
eases. In cestodes, little is known about the functional properties of G protein coupled
receptors (GPCRs) which have proved to be highly druggable targets in other organisms.
Notably, serotoninergic G-protein coupled receptors (5-HT GPCRs) play major roles in key
functions like movement, development and reproduction in parasites.
Methodology/Principal findings
Three 5-HT GPCRs from Echinococcus granulosus and Mesocestoides corti were cloned,
sequenced, bioinformatically analyzed and functionally characterized. Multiple sequence
alignment with other GPCRs showed the presence of seven transmembrane segments and
conserved motifs but interesting differences were also observed. Phylogenetic analysis
grouped these new sequences within the 5-HT7 clade of GPCRs. Molecular modeling
showed a striking resemblance in the spatial localization of key residues with their mamma-
lian counterparts. Expression analysis using available RNAseq data showed that both E.
granulosus sequences are expressed in larval and adult stages. Localization studies per-
formed in E. granulosus larvae with a fluorescent probe produced a punctiform pattern
concentrated in suckers. E. granulosus and M. corti larvae showed an increase in motility
in response to serotonin. Heterologous expression revealed elevated levels of cAMP
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production in response to 5-HT and two of the GPCRs showed extremely high sensitivity to
5-HT (picomolar range). While each of these GPCRs was activated by 5-HT, they exhibit
distinct pharmacological properties (5-HT sensitivity, differential responsiveness to ligands).
Conclusions/Significance
These data provide the first functional report of GPCRs in parasitic cestodes. The serotonin-
ergic GPCRs characterized here may represent novel druggable targets for antiparasitic
intervention.
Author summary
Cestode parasites are flatworms with the ability to parasitize almost every vertebrate spe-
cies. Several of these parasites are etiological agents of neglected diseases prioritized by
WHO, such as hydatid disease, or hydatidosis, a zoonosis caused by species of the genus
Echinococcus that affects millions of people worldwide. Due to the scarcity of anthelmintic
drugs available and the emergence of resistant parasites, the discovery of new anthelmintic
drugs is mandatory. Neuromuscular function has been the target of commonly used
drugs against parasitic diseases to impact movement, parasite development and reproduc-
tion. Here we describe three new proteins, some of them highly expressed in cestodes
which could be relevant for motility. Using different approaches, the three proteins were
identified as G protein coupled receptors for serotonin, an important neurotransmitter
and a known modulator of cestode motility. These new receptors exhibit unique charac-
teristics including a particular sensitivity to serotonin as well as a distinctive pharmacol-
ogy, which will assist their targeting for chemotherapeutic intervention.
Introduction
The parasitic flatworms Echinococcus granulosus sensu lato (s. l.) and Mesocestoides corti are
tapeworms belonging to the class Cestoda, with E. granulosus s. l. belonging to Taeniidae and
M. corti to Mesocestoididae family. The Echinococcus species are important parasites of wildlife,
domestic animals and people worldwide. The larval stage of almost all parasites of the E. granu-
losus s. l. complex (which includes the species Echinococcus granulosus sensu stricto and Echino-
coccus canadensis) cause human cystic echinococcosis or hydatidosis, one of the 17 neglected
diseases prioritized by WHO [1]. The larval stage (tetrathyridia) of M. corti has a remarkable
capacity of asexual reproduction in the peritoneal cavity of mice and some other mammalian
hosts [2]. This parasite is a well established model for laboratory studies and the tetrathyridium
is used to examine drug effects on neuromuscular activity [3].
According to Mansour [4] the survival of parasitic helminths in their natural habitat is
dependent on their ability to maintain themselves in situ in the face of peristaltic, blood or
lymph movements. Most cestode parasites have specialized sucker-like organs to move within
and attach to the host. They also exhibit well-coordinated rhythmical movements which could
help to locate and maintain themselves in the host [4] or to serve the reproductive function in
the parasite [5]. Any interference with coordination of the parasite movement could result in
conveyance to an environment hostile for their survival or expulsion from the host [6]. These
important functions can be accomplished only by the activity of different kind of muscles [7]
innervated by a well-developed nervous system.
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Serotonin or 5-hydroxytryptamine (5-HT) is an ancient molecule and neurotransmitter
with diverse roles in organisms [8]. In invertebrates, the action of 5-HT on neuromuscular
junction depends on the species and the type of preparation under consideration [9]. For
example, in insects it has been shown that application of 5-HT on neuromuscular junctions
appears to slightly depress synaptic strength [10]. In crustaceans, it has been demonstrated
that 5-HT enhances synaptic transmission at neuromuscular junctions [11]. In the leech, 5-HT
exposure has a relaxing effect on skeletal muscle but enhances muscle force and work produc-
tion during locomotion and feeding [12]. Finally, in the sea cucumber, 5-HT inhibited evoked
contractions induced by acetylcholine [13].
Mansour et al. [14] were among the first investigators who reported the existence of 5-HT
in parasitic helminths. Work in free living planarians also highlights the diversity of serotonin
receptors in flatworms [15]. Functionally, 5-HT is myoexcitatory in several species of cestodes
and trematodes [3, 4, 16, 17]. However, the mechanism by which 5-HT exerts these effects
remains unclear: recent work proposed the action on 5-HT receptors located on nerves [18],
older reports suggest a direct effect in muscles [7], with a combination of both these effects
being likely. Finally, other studies relate the motility of these worms with the activation of the
glycolytic enzyme phosphofructokinase [19]. The diversity of effects is presumably enabled
through the existence of multiple 5-HT receptors [20]. Evidence has accumulated that 5-HT
receptors can signal through cyclic AMP (cAMP) [7, 21] and PKA [22] although other second
messenger pathways may also be involved [20].
The seminal idea of Mansour [17] about the potential use of 5-HT receptors as pharmaco-
logical targets in parasites has received support from recent data in planarians [23] and Schisto-
soma mansoni [18, 24, 25]. Pharmacological profiling of heterologously expressed flatworm
5-HT receptors revealed different pharmacological profiles between parasitic and human sero-
tonin receptors and inhibitory effects of various 5-HT antagonists on motility [25]. These data
strongly suggest that 5-HT receptors from parasites could be used as targets for pharmacologi-
cal intervention [25].
With the exception of 5-HT3, which is a serotonin gated ion channel, serotonin receptors
belong to the rhodopsin family or the class A of G-protein coupled receptors (GPCRs). GPCRs
respond to a broad range of physicochemical entities ranging from photons, protons, calcium
ions, and small molecules encompassing odorants, neurotransmitters, peptides and glycopro-
teins, making GPCRs versatile chemical sensors [26]. Indeed the senses of sight, smell and
taste are mediated by GPCR signalling. Given the central role played by GPCRs in nearly all
physiological processes, they represent attractive targets for drug discovery across a broad
spectrum of diseases [26]. Serotoninergic pathways have been implicated in the aetiology of
numerous disease states, including depression, schizophrenia, anxiety, social phobia, migraine,
obsessive–compulsive and panic disorder [27]. Some selected examples of therapies are: cloza-
pine, an effective agent for chronic schizophrenia [28]; the 5-HT1A receptor partial agonist
buspirone, used as an anxiolytic [28]; the antipsychotic risperidone, which targets serotoniner-
gic and dopaminergic receptors [28] and sumatriptan, a selective 5-HT1 receptor agonist used
for migraine [28, 29]. Recent data demonstrate the anthelmintic praziquantel is itself a human
serotoninergic ligand [30].
The availability of genome data from Echinococcus spp [31, 32, 33] and M. corti (http://
parasite.wormbase.org/ Mesocestoides_corti_prjeb510 / Info / Index /, Helminth Genomes
Consortium) has now permitted us to search for 5HT-GPCR coding genes in these cestodes.
Currently, the treatment used for echinococcosis and other cestode infections in humans
relies on benzimidazoles, mainly albendazole, which is used alone or in combination with pra-
ziquantel [34, 35]. However, arising of resistance to albendazol and also to praziquantel was
reported for many helminths [35, 36]. These drugs have been reported to be ineffective in 40%
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of cases [34], are only parasitostatics (specially for E. multilocularis), requiring of life-long
treatments and are not tolerated by many patients [37]. The scarcity of anthelmintic drugs
available and the emergence of resistant parasites, makes the discovery of new anthelmintic
drugs an imperative need. One possible way to achieve this goal is to characterize G-protein
coupled receptors in cestodes as potential pharmacological targets.
In this work, we analyzed the effect of 5-HT on motility of the tetrathyridia of M. corti. The
evidence for involvement of 5-HT receptors in the cestode neuromuscular activity was rein-
forced by the utilization of a fluorescent probe derived from a potent agonist for the human
serotoninergic receptor 5-HT1A [38]. Isolation, sequencing, bioinformatic characterization
and functional testing of 5-HT GPCRs were performed in two species of cestodes, with priori-
tized sequences modeled to identify characteristics that could be critical for receptor function.
Overall, our work assesses the importance of 5-HT in the neuromuscular activity of cestodes,
and identifies new 5-HT GPCRs as potential targets for drug therapy.
Methods
Bioinformatic analysis
Gene models coding for metabotropic 5-HT receptors were searched using the terms
“5-hydroxytryptamine receptor”, “serotonin receptor”, “biogenic amine 5-HT receptor”, “G
protein coupled 5 hydroxytryptamine receptor” in Echinococcus multilocularis [31], Echinococ-
cus granulosus [32], Echinococcus canadensis [33] and Mesocestoides corti (http://parasite.
wormbase.org/Mesocestoides_corti_prjeb510/Info/Index/, Helminth Genomes Consortium)
databases. The retrieved gene models were also used as a query in the Blast tool from the NCBI
for nucleotide (BLASTN 2.7.0+) and proteins (BLASTP 2.7.0+). The presence of conserved
domains in the gene models found was determined using the Conserved Domain Database
tool from the NCBI (https://www.ncbi.nlm.nih.gov/cdd/). The prediction of hypothetical open
reading frames from nucleotide sequences was performed using the translate tool from the
expasy proteomic tools (http://web.expasy.org/translate/). The localization and length of trans-
membrane domains was predicted using TMpred (http://embnet.vital-it.ch/software/
TMPRED_form.html). The multiple sequence alignment was performed using the program
MULTALIN [39] from PRABI (https://npsa-prabi.ibcp.fr/cgi-bin/npsa_automat.pl?page=/
NPSAHLP/npsahlp_alignmultalin.html). The multiple sequence alignments were then visually
inspected and manually edited when necessary. The molecular weight and isoelectric point of
the predicted proteins was calculated with the program Compute pI/Mw tool (http://web.
expasy.org/compute_pi/).
Cloned 5-HT7Egran1, 5-HT7Egran2 and 5-HT7Mco1 and predicted cestode sequences gene
models ECANG7_00799 (5-HT1Egran1), ECANG7_02049 (5-HT1Egran2) and MCOS_0000684301
(5-HT7Mco2) were aligned with cloned serotonin receptor sequences from the following inverte-
brates; Dugesia japonica (5-HT1Dj1 to 5-HT1Dj3, 5-HT4Dj1 to 5-HT4Dj5, 5-HT7Dj1 to 5-HT7Dj7,
PMCID: PMC4569474), Schistosoma mansoni (5-HT7Sm, GenBank accession number KX150867),
Caenorhabditis elegans (UniProt IDs G5EGH0 for 5-HT1Ce, O17470 for 5-HT2Ce and Q22895 for
5-HT7Ce) and Drosophila melanogaster GenBank accession numbers CAA77570.1 (5-HT1ADro),
CAA77571.1 (5-HT1BDro), CAA57429.1 (5-HT2ADro), NP_001262373.1 (5-HT2BDro) and
NP_524599.1 (5-HT7Dro). Alignment of amino acid sequences was performed with Clustal Omega
v1.2 [40], gaps removed with Gap Strip/Squeeze v2.1.0 (75% gap tolerance) [41], and an unrooted
maximum likelihood phylogenetic tree was generated with PhyML v3.1 (500 bootstrap replicates)
[42].
For molecular modelling studies, proteins studied in this work were searched using BLAST
[43] against UniProtKB/Swiss-Prot databases. Protein domains were screened against PFAM,
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and Prosite databases using PFAM_scan [44] or HMMscan 3.0. Protein structure models were
obtained using PHYRE2 [45] and SWISS-MODEL [46–49]. PDB database was used for homol-
ogy searching and 3SN6 and 4IAR with ergotamine ligand (http://www.rcsb.org/pdb) [50] was
used for structural comparison analyses. For all the new sequences, the template used to model
the transmembrane segment of the protein was the deposited structure 3SN6, and the internal
segment (intracellular loop 3) modelled using Phyre using the template 2RH1. Ramachandran
Plots were produced using Rampage (http://mordred.bioc.cam.ac.uk/~rapper/rampage.php).
Relevant and conserved protein residues for the ligand binding were identified and its dis-
tances from the ligand were measured. Analysis of the 5-HT7Egran1 modeled protein revealed
that 91.7% of the residues are within the favoured regions, 4.3% in allowed regions and 4% in
outlier regions of the Ramachandran plots. For the modeled 5-HT7Egran2 protein, 88.6% of the
residues are within the favoured regions, 8.3% in allowed regions and only 3,1% in outlier
regions were as for 5-HT7Mco1, 85.3% of the residues are within the favoured regions, 9.5% in
allowed regions and 5,2% in outlier regions. All this data shows the good quality of the gener-
ated homology models (S1A, S1B and S1C Fig).
Chemicals
Compounds UCM120 and UCM2550 were synthesized as described previously [38, 51] and
dissolved in DMSO before dilution to the needed concentration. Ergotamine and tryptamine
were also dissolved in DMSO whereas Lysergic acid diethylamide (LSD), tyramine, octopa-
mine, acetylcholine, histamine and dopamine were dissolved in distilled H2O. 5-HT was dis-
solved in distilled H2O at stock concentration of 5 mM. Stock solutions were either made up
on the day of the experiment or taken from aliquots stored at -80˚C for no longer than 1 week
prior to use. After 0.22 μm filtration with Millex GV filter units (Millipore, Ireland), stock solu-
tions were diluted to the corresponding final concentration (e.g. 0.1; 1; 10; 100; 500; 1000 and
2000 μM for 5-HT) in RPMI medium with high glucose (Gibco, USA). 5-HT (H9523), LSD
(L7007), ergotamine (E1200000), tryptamine (193747), tyramine (T90344), octopamine
(O0250), acetylcholine (A6625), histamine (H7125) and dopamine (H8502) were obtained
from Sigma Chemical Company.
Parasite material
Echinococcus granulosus protoscoleces were obtained under sterile conditions by needle aspira-
tion of hepatic hydatid cysts of porcine origin, provided by abattoirs from Buenos Aires and
Santa Fe provinces, Argentina. The livers used for parasite extraction were from animals that
were not specifically used for this study and all the material obtained was processed as part of
the normal work of the abattoir. Samples from animals at the abattoir were collected under
consent from local authorities. Protoscolex viability was assessed using the eosin exclusion test
after three washes with PBS, with 50 μg/ml of gentamicin to remove cyst wall debris [52]. Only
samples showing more than 95% viability were used. A fraction of the protoscoleces was used
for probe imaging, other fraction for motility experiments and the remaining protoscoleces
were used for species/genotype determination by sequencing a fragment of the mitochondrial
cytochrome c oxidase subunit 1 (CO1), as previously described [53]. The resulting species and
genotype of all protoscoleces used in this work were from Echinococcus canadensis G7. Three
biological replicates were used with each replicate corresponding to protoscoleces obtained
from a single cyst. Mesocestoides corti larvae (tetrathyridia) were maintained by alternate, serial
passages in Wistar female rats and BALB/c female mice as previously described [54]. The
tetrathyridia larvae used in drug testing were obtained after 3 months of intraperitoneal inocu-
lation. Only tetrathyridia from up to the third serial passage in mice were used for the
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experiments. Three biological replicates were used with each replicate corresponding to tetra-
thyridia obtained from a single mouse host. Larvae freshly collected from mice were washed
three times in PBS and used immediately for drug tests.
Wistar female rats and BALB/c female mice were housed at the animal facilities of Instituto
de Investigaciones en Microbiologı´a y Parasitologı´a Me´dica (IMPaM), Facultad de Medicina,
Universidad de Buenos Aires (UBA)-Consejo Nacional de Investigaciones Cientı´ficas y Tecno-
lo´gicas (CONICET), Buenos Aires, Argentina, in a temperature-controlled light cycle room
with food and water ad libitum.
Ethics statement
Experiments involving the use of experimental animals were carried out according to proto-
cols approved by the Comite´ Institucional para el Cuidado y Uso de Animales de Laboratorio
(CICUAL), Facultad de Medicina, Universidad de Buenos Aires, Argentina (protocol “in vivo
passages of cestode parasites from Mesocestoides corti” number CD N˚ 1127/2015). Cyst punc-
ture was performed following the approved protocol by the same institution (protocol “Hyda-
tid cysts puncture from natural infections” number CD N˚ 3723/2014).
RNA extraction and cDNA synthesis
Total RNA from E. granulosus was extracted from protoscoleces that were crushed under liq-
uid nitrogen and processed using Trizol reagent (Invitrogen). The RNA obtained was treated
with RNase-Free DNase (Fermentas), ethanol precipitated and reverse transcribed using
Superscript III reverse transcriptase (RT) (Invitrogen) and gene specific reverse primer com-
plementary to 5-HT GPCR gene models (S1 Table). One cDNA for each selected gene model
was synthesized. The same procedure was followed to obtain RNA from M. corti tetrathyridia
and cDNA synthesis.
Amplification and cloning of cDNAs coding for serotoninergic GPCRs
The gene models ECANG7_06088 and ECANG7_06092 from E. granulosus and MCOS_
0000684401 from M. corti, retrieved as explained in the section “Bioinformatic analysis” were
used for primer design (S1 Table) and a PCR product for each serotoninergic GPCR was
obtained. The cycling parameters for ECANG7_06088 were 95˚C for 5´ (initial denaturaliza-
tion), then 98˚C for 20´´, 56˚C for 30´´ and 72˚C for 2´ (repeated 5 times), then 98˚C for 20´´,
66˚C for 30´´ and 72˚C for 2´ (repeated 35 times) and finally, 72˚C for 10´ (final extension).
For ECANG7_06092 were 95˚C for 5´ (initial denaturalization), then 98˚C for 20´´, 55˚C for
30´´ and 72˚C for 2´ (repeated 5 times), then 98˚C for 20´´, 64˚C for 30´´ and 72˚C for 2´
(repeated 35 times) and finally, 72˚C for 10´ (final extension). Finally, for MCOS_0000684401
were 95˚C for 5´ (initial denaturalization), then 98˚C for 20´´, 55˚C for 30´´ and 72˚C for
2´ (repeated 5 times), then 98˚C for 20´´, 72˚C for 30´´ and 72˚C for 2´ (repeated 35 times)
and finally, 72˚C for 10´ (final extension). PCR reactions were performed using the KAPA
HIFI polymerase (Biosystems) using the cDNA previously obtained with each reverse primer
as a template. Amplification products were visualized by agarose gel electrophoresis and Gel
Red staining and the bands of interest were extracted from the gel using the QIAquick Gel
Extraction Kit (Qiagen), used for a non-templated adenine adding or A-tailing procedure
employing a nonproofreading DNA polymerase (Pegasus, Embiotec) and finally cloned into
the TOPO TA Vector (Invitrogen). The recombinant plasmids were used for Escherichia coli
(DH5α) transformation and the transformed bacteria were grown in LB with ampicillin and
kanamycin.
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The selected colonies were then used for plasmid purification using the GeneJet Plasmid
miniprep kit (Fermentas) and sequencing using an Applied Biosystems Big Dye terminator
kit (Applied Biosystems) on an ABI 377 automated DNA sequencer. The cloned cDNA prod-
ucts obtained with E. granulosus primers were designed from the ECANG7_06088 and
ECANG7_06092 gene models and named 5-HT7Egran1 and 5-HT7Egran2 respectively (S1 Text)
following the naming scheme proposed by Tierney [55]. The cDNA cloned from the gene
model MCOS_0000684401 from M. corti was named 5-HT7Mco1 (S1 Text).
Motility index measurement
For the motility index measurement, the method of Camicia et al. [16] was followed with
minor modifications. In the case of E. granulosus, protoscoleces were mantained in RPMI
medium with high glucose (Gibco, USA) with 50 μg/ml of gentamicin for no more than 48
hours in order to avoid the potential differentiation of the protoscolex towards premicrocyst
[16]. The day before the experiment the protoscoleces were transferred to U-shape 96-well
microplates (Greiner Bio-One, Germany) with approximately 125 parasites per 100 μl per well.
This number of parasites per well was empirically determined as the best number of worms to
perform the experiments. Movement was measured as described for C. elegans [56] using a
worm tracker device (WMicrotracker Designplus SRL, Argentina) which determines the
motility index by the light-microbeam (100 μm wide; k = 880 nm; intensity<1 mW) scattering
produced by the movement of parasites. Quantification of the signal was performed by apply-
ing a mathematical algorithm previously described for sperm viability determination (Patent
number: US4176953, year of submission: 1978, year of publication: 1979).
To study the effect of 5-HT on the motility of M. corti tetrathyridia, only one worm per well
was used as this was the empirically determined optimal number. Addition of more tetrathyri-
dia to each well plate did not result in a better signal. M. corti tetrathyridia were used fresh,
immediately after the mice was opened. One tetrathyridium per well in 100 μl of RPMI with
high glucose (Gibco) was pipetted to U-shape 96-well microplates and incubated overnight at
37˚C in a 5% CO2 atmosphere. The following day, basal activity recordings were performed
for 2 h at 37˚C in the worm tracker. After the initial 2 h, 25 μl of the same medium containing
5-HT at the indicated concentrations were added and the motility of parasites was recorded in
the resultant 125 μl of medium for another 2 hours. Twenty-five microliters of fresh medium
alone were added to the controls before registering motility in the resultant 125 μl. In order to
avoid any potential difference between individuals not related to the effect of the 5-HT, the
activity found in each well was divided by the activity found in the same well in the basal
record. Each experiment was performed using 16 technical replicates per treatment condition.
In order to count with biological replicates, four independent experiments, with tetrathyridia
coming from different mice were performed.
Effect of the 5-HT GPCR agonist UCM2550 on cestode larval motility
We evaluated the effect of UCM2550, a 5-HT1A agonist in mammals and the parent ligand of
UCM120, [38, 57] on protoscolex movement. Protoscoleces were incubated in 96-well
microplates as described in the section “Motility index measurement”, and basal activity was
registered for 2 hours at 37˚C. After this first acquisition they were subjected, in groups of 16
replicates, to the inidicated concentrations of the previously mentioned drug, and recorded
for an additional 2 hours in the resultant 125 μl. Control wells were incubated in 125 μl
of medium with or without 2% of DMSO (the vehicle used to dissolve the drugs) and no dif-
ferences were observed between those groups. Three independent experiments, with
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protoscoleces from different hydatid cysts (biological replicates), were performed. The effect
of the drug on protoscolex viability was tested for toxicity at the maximal concentrations
used.
Measurement of motor activity by video imaging
In some experiments, alongside to the worm tracker motility analyses, the parasite motor
activity was also measured with a digital video camera (Kodak easy share Z915 digital camera)
coupled to an inverted microscope (Nikon, model TMS-F). Fresh parasites were processed in
the same way as in previous sections in U-shape 96-well microplates, then incubated overnight
at 37˚C in a 5% CO2 atmosphere and finally video recorded with a digital camera after drug
treatment. Images were obtained for a period of 15 seconds and the data were analyzed with
ImageJ software (version 1.48, NIH, USA). Protoscoleces showed complex motor movements
characterized by sucker and rostellum movements and repeated body bends. To quantify this
type of movements the method of Patocka et al. [18] was followed with some modifications.
The videos were transformed to stacks of TIFF images by using the Filmora video editor
(Wondershare Filmora, version 8.2.3, downloaded from https://filmora.wondershare.es/) and
then imported into ImageJ. First, the stacks were first converted to 8 bit type images. Next, the
background was subtracted and then converted to a binary image by threshold adjust. Then,
the maximum intensity of Z projection (which shows all the elements in the movie) was calcu-
lated together with the minimum intensity projection (which shows only the constant ele-
ments in the movie). Then subtracting the minimal from maximal projections with the “image
calculator” it was possible to remove everything constant in the movie, including immobile
animals. Finally, the resultant pixels were quantified using the “Analyze particles” command
and the integrated density in the summary result table showed the pixels that changed during
the course of each movie. This procedure was repeated for each video and a graphic represen-
tation of pixel change was done for each treatment (S2 Fig). Eight technical replicates and
three independent experiments, with protoscoleces coming from different hydatid cysts (bio-
logical replicates), were performed.
Whole mount probe imaging
Protoscoleces were fixed for 4 hours at room temperature (RT) in 4% (w/v) paraformaldehyde
(PFA) in PBS (pH 7.4) and washed for 24 hours at RT in PBS containing 0.35% (v/v) triton X-
100 (TX-100), 0.1% (w/v) sodium azide (NaN3), 0.1% (w/v) BSA (Sigma), 6.25 x 10
−3 (w/v)
digitonin (Dig) and 0.5% DMSO (PBS/TX-100/NaN3/BSA/Dig/DMSO). Approximately, 10 μl
of pellet of protoscoleces were aliquoted in eppendorf tubes and incubated for 120 hours (five
days) at 4˚ C in the presence of 100 μM of the probe UCM120 (which is a 5-HT1A agonist in
mammals labeled with a dansyl group as fluorescent tag) [38] in constant agitation in a final
volume of 300 μl. Specimens were then washed three times with PBS and fixed for 3 hours at
room temperature (RT) in 4% (w/v) paraformaldehyde (PFA) in PBS/TX-100/NaN3/BSA/Dig/
DMSO. The protoscoleces were washed again, mounted in glycerol/PBS (8:1 v/v) and then
viewed under standard fluorescence microscope (Nikon Eclipse E600) or in a confocal scan-
ning laser microscope (CSLM, Fluoview 1000 Olympus). The individual pictures obtained
from the optical sections were used for the reconstruction of the whole specimen using the
program ImageJ. In order to determine if the signal obtained was specific, several controls
were run in parallel: protoscoleces without probe or protoscoleces in the presence of 1000 μM
of serotonin as negative control. This experiment was performed several times with similar
results.
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Levels of GPCR expression
The transcriptional expression levels (in RPKM, or reads per kilobase per million reads) for
each serotoninergic receptor in Echinococcus granulosus sensu stricto (G1 genotype) were from
Zheng et al. ([32], Supplementary Table 28).
Cell culture and cAMP assays
HEK-293 cells (ATCC CRL-1573.3) were cultured in growth media [DMEM (Gibco), 10%
heat inactivated fetal bovine serum (Gibco), penicillin (100units/mL), streptomycin (100μg/
mL) and L-glutamine (290μg/mL)] and used for assays between passages 5 and 25. For cestode
GPCR heterologous expression assays, cells were transfected (Lipofectamine 2000, Invitrogen)
at 80% confluency approximately 16 hours after seeding within T-25 culture flasks with a 1:1
ratio of human codon optimized cestode GPCR cDNA (subcloned into a pcDNA3.1(-) mam-
malian expression vector) and cDNA encoding the pGloSensor 22-F plasmid (Promega). The
following day, cells were trypsinized, centrifuged (300g/5min), resuspended in DMEM supple-
mented with 1% dialyzed FBS (Gibco) and plated in 96 well, solid white plates (Corning, cat #
3917). After overnight culture to allow adherence, media was exchanged for assay buffer
(HBSS supplemented with 0.1% BSA, 20mM HEPES (pH 7.4), and GloSensor reagent (Pro-
mega). cAMP-luminescence assays were performed following addition of a phosphodiesterase
inhibitor (3-isobutyl-1-methylxanthine, IBMX; 200μM) using a GloMax-Multi Detection Sys-
tem plate reader (Promega) as described previously [24].
Statistical analyses
Statistical analyses were carried out using the GraphPad Prism Software package, version 6 for
Windows (GraphPad Software, CA, USA). To analyze the effects of serotonin in motility assays
performed with the WMicrotracker device, the relative motility indices of all replicate wells for
each concentration of the different independent experiments were made into one cohort for
one-way ANOVA. To determine significant differences a Bonferroni and Dunnett post-tests
were performed comparing all concentrations with the control. In the experiment evaluating
the effects of UCM2550 on protoscolex motility, the mean motility index obtained with the
WMicrotracker was compared before and after the addition of the drug with a Student’s t-test.
For image based assays, pixel changes in control and treatments were calculated and analyzed
with one way ANOVA and Dunnett post-test were performed comparing all the concentra-
tions with the control. Differences from control with P < 0.05 were considered statistically sig-
nificant inductions or inhibitions of motor activity.
Results
Cloning, sequencing and bioinformatic analysis of serotoninergic GPCRs
in two cestode species
Six gene models in total were retrieved by blast searches from which four gene models were
from Echinococcus spp. databases and only two from the M. corti database. From all them, only
ECANG7_06088, ECANG7_06092 (E. granulosus) and MCOS_0000684401 (M. corti), were
used for primer design since the rest of the gene models were either incomplete (lacking one
or more transmembrane segments), or missing important residues for function, or they could
not be amplified in PCR reactions. By using sequence specific primers, three cDNAs were
cloned by standard RT-PCR being two of the sequences obtained from E. granulosus (5-HT7E-
gran1 and 5-HT7Egran2) and one from M. corti (5-HT7Mco1). The 5-HT7Egran1 cDNA has 2100 bp
and encodes a protein of 659 amino acids with a predicted molecular weight of 73.8 kDa and a
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pI close to 10 (pI = 9.83). The second cDNA cloned, 5-HT7Egran2, has 1731 bp and encodes for
a protein of 576 amino acids with a predicted molecular weight of 65 kDa and a pI close to 9
(pI = 9.12). Finally, the M. corti cDNA 5-HT7Mco1, has 2091 bp and encodes for a protein of
696 amino acids with a predicted molecular weight of 78.6 kDa and a pI of 9.45. Domain
searches showed that all the cloned sequences have best hits with the 5-HT7 domain of seroto-
nin receptors. S3 Fig shows a multiple sequence alignment between the Homo sapiens, C. ele-
gans, S. mansoni, E. granulosus and M. corti sequences encoding for serotoninergic G-protein
coupled receptors. The bioinformatic analysis of the cloned sequences shows several charac-
teristics of the molecular signature of a GPCR. For example, all three sequences have seven
conserved hydrophobic transmembrane segments consistent with GPCR architecture (S3
Fig). Topological modeling (TMpred) predicts an extracellular N-terminus and an intracel-
lular C-terminus. Intracellular loop 3 and, for 5HT7Egran1 and 5HT7Mco1 the carboxy-termi-
nal regions, were longer than the corresponding regions in the human counterpart (S3 Fig).
The multiple sequence alignment also highlights conserved amino acid residues that are
invariant within the rhodopsin family of GPCRs [58]. The first of them is the DRY motif
present in the third transmembrane domain probably involved in the stabilization of the
ground state [59, 60]. The second relevant motif found was the NPxxY motif located toward
the cytoplasmic end of the seventh transmembrane domain and potentially implicated as
crucial in the recruitment of β-arrestin, which is a mechanism of receptor inactivation [59–
61]. The third is the PIF motif, which is a critical trigger motif for receptor activation [59,
60]. And the last one, in the transmembrane segment 6, there is a cluster of aromatic residues
referred as “toggle switch” in which it was reported that the movement of some of these resi-
dues could be important for receptor activation [60]. Taking the residue position from the
human 5HT1B receptor as a reference sequence [62] and the Ballesteros and Weinstein
nomenclature [63], the residues conserved in all the cestode sequences were: C1223.25
which makes putative disulphide bond contact with the C199El2 in the extracellular loop 2;
D1293.32, which forms a salt bridge with the positively charged amino group of ergotamine
in the human receptor [62]; C1333.36, which recognizes the amine portion of the ligand;
T1343.37, which forms hydrogen bond with the indole group; A2135.46, which interacts with
the indole ring in the ligand; W3276.48, F3306.51 and F3316.52, which form the orthosteric
binding pocket. The residue Y3597.43 is hypothesized to form hydrogen bond with N6 of
ergotamine in the human receptor. The residue conserved in all but not in 5-HT7Egran2, is
T2165.43, which interacts with the indole ring in the ligand and is replaced by C in this posi-
tion in the 5-HT7Egran2 sequence. The conserved S215
5.42 of TM5 is replaced by alanine in all
the cestode sequences and, interestingly, the same substitution was observed in the S7.1
receptor from the planaria D. japonica [15] and also in the Sm5HTR from S. mansoni [18].
TM5 residues (S4 Fig) are important players in ligand recognition [62, 64]: with the excep-
tion of the alanine at position 5.42, the other crucial residues (5.43 and 5.46) are conserved
in mammalian serotonin receptors, particularly in subtypes 1 (5-HT1) and 7 (5-HT7).
Besides ligand binding, other residues potentially involved in G protein contacts could be
identified (S3 Fig). For example, the residue L3166.37 in the cytoplasmic end of TM6 upon
activation contacts a universally conserved leucine of the G protein in the β2 adrenergic
receptor-Gs structure [65]. Moreover, in the V155 position of the human 5-HT1 receptor
(F139 in the human beta 2 adrenergic receptor), located in the IL2 helix, it was reported a
F (phenylalanine) or L (leucine) for Gs coupling which is coincident with the residues
observed in serotonin receptors from cestodes at this position [66] (S3 Fig). The phylogenetic
analysis (Fig 1) shows that all the cloned sequences grouped with the 5HT7 subtype (S7-
like clade) of invertebrate serotoninergic G-protein coupled receptors, which are Gs coupled
[67].
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The transcriptomic data reveals a highly expressed receptor at the
protoscolex stage
Transcriptomic data obtained from Zheng and coworkers [32], reveals that two of the recep-
tors cloned here (5-HT7Egran1 and 5-HT7Egran2) are highly expressed in the activated protosco-
lex stage (S5 Fig) with the levels of expression of 5-HT7Egran2 being particularly high. The levels
of expression of both receptors in activated protoscolex stage are at least fourfold higher
than those observed in other stages of the parasite. No expression of these two receptors was
detected in the oncosphere.
Fig 1. Cladogram of cestode and invertebrate serotoninergic GPCRs. The amino acid sequences of predicted cestode serotonin receptors were aligned with the
repertoire of serotonin receptors cloned from various other flatworm and non-flatworm invertebrate model organisms; Dugesia japonica, 5-HTDj; Schistosoma
mansoni, 5-HTSm; Caenorhabditis elegans, 5-HTCe; Drosophila melanogaster, 5-HTDm. The cestode GPCR sequences cloned and functionally expressed in this
study (5-HT7Egran1, 5-HT7Egran2, 5-HT7Mco1) cluster within a clade of 5-HT7 like receptors (green), as does an additional predicted M. corti sequence
(5-HT7Mco2). Other predicted cestode serotoninergic sequences (5-HT1Egran1 and 5-HT1Egran2) cluster within a clade of 5-HT1 like receptors (blue). See methods
for complete list of UniProt and GenBank sequence identifiers used in this analysis. Analysis was bootstrapped with 500 replicates.
https://doi.org/10.1371/journal.pntd.0006267.g001
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Molecular modelling of 5-HT7Egran1, 5-HT7Egran2 and 5-HT7Mco1
Molecular models of 5-HT7Egran1, 5-HT7Egran2 and 5-HT7Mco1 were developed to explore
potential structural similarities and differences between the parasitic and human receptors. Fig
2 shows the models of each cloned serotoninergic GPCR compared with the crystal structure
of human 5-HT1BR (4IAR) [62]. A striking structural similarity in the transmembrane
domains can be observed (Fig 2, models A, C and E). According to the models obtained, four
important interactions with ergotamine could occur at the transmembrane segments three
(III) and five (V), (Fig 2, models B, D and F). The indicated residues comprise part of the
orthosteric binding pocket of the cestode GPCRs.
Serotonin increases the motility of Mesocestoides corti tetrathyridium
Previously, we have shown that 5-HT induces E. granulosus protoscolex motility [16]. In spite
of some evidence about 5-HT action on M. corti motility [3], the kinetics of this important
neurotransmitter in motility over longer periods of time (>30 minutes) was unknown. For
this reason, we analyzed further the effect of 5-HT on the larvae of M. corti. The addition of
serotonin to tetrathyridia resulted in the stimulation of the motility above basal levels (S6 Fig,
S1 Video). The channel activity traces show a stimulation in frequency of movement at high
doses of 5-HT compared to the basal condition (S6A Fig). The dose-response curve showed a
significant rise of motility starting from 100 μM of 5-HT (p< 0.05) until the highest concen-
tration tested of 2000 μM over a period of two hours (p< 0.001; S6B Fig). Dose-response
curves were also collected over different intervals of time (30, 60, 90 and 120 minutes). These
graphs showed that the shape of the curve changes with time (S6C Fig). At the highest concen-
trations tested (500 to 2000 μM), the relative motility tends to drop with time after the first 30
minutes of incubation, losing their significance respect to control, probably reflecting an inac-
tivation process. At the lowest dose (100 μM) the motility tends to rise during the first 90 min-
utes of incubation and then also it tends to fall after 120 minutes of incubation (S6C Fig).
Similar concentrations of 5-HT (1000 μM; p< 0.001) are necessary to see significant
changes in motility over a period of 30 minutes by video imaging (S6D Fig).
Functional expression and pharmacological profiling show activation by
5-HT with distinct pharmacological properties
Based on the bioinformatic prediction that these sequences encode serotoninergic GPCRs,
responses to 5-HT were compared between cells expressing individual cestode GPCRs and
untransfected cells. For each of the clones, addition of 5-HT in transfected cells evoked a rapid
and dose dependent stimulation of cAMP accumulation (Fig 3A, 3B & 3C). One notable fea-
ture of two of the GPCRs– 5-HT7Egran2 and 5-HT7Mco1 –was resolution of a background rate of
cAMP accumulation immediately on IBMX addition prior to addition of 5-HT (the period
between the arrows in Fig 3B & 3C). This was not observed with the 5-HT7Egran1 clone (Fig
3A). Because of this basal coupling, the fold-change in luminescence signal on addition of
5-HT was lower with– 5-HT7Egran2 (~3.3-fold) and 5-HT7Mco1 (~2.5-fold) than observed in
cells expressing 5-HT7Egran1 (~20-fold). Full dose response relationships were performed for
each GPCR, and compared with endogenous responses to the same concentrations of 5-HT in
untransfected cells (Fig 3D, 3E & 3F). The EC50 for 5-HT evoked cAMP generation was 171
±57nM in cells expressing 5-HT7Egran1. For the two GPCRS exhibiting basal coupling, the EC50
for 5-HT evoked cAMP production was in the picomolar range measured as 543±107pM for
5-HT7Egran2 and 255±63pM for 5-HT7Mco1. Responses to 5-HT were considerably smaller in
untransfected cells (Fig 3D, 3E & 3F). To investigate the specificity of these GPCRs for 5-HT,
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responses to higher concentrations (10μM) of other neurotransmitters (tryptamine, tyramine,
octopamine, histamine, dopamine and acetylcholine) were examined (Fig 4). In all cases,
5-HT elicited maximal cAMP accumulation. At higher doses (10 μM), tryptamine also proved
Fig 2. Molecular modeling of serotoninergic receptors from cestodes. The structural similarities between three cestode
receptors and the published structure of the serotoninergic receptor from human (4IAR) are shown. A) Model of the serotonin
receptor 5-HT7Egran1 (Brown) superposed to the published structure of the human serotonin receptor 5-HT1B (blue). B) Close
view of the putative ergotamine interaction with residues of the transmembrane domains III and V from 5-HT7Egran1 (lateral
chains of the amino acids involved are indicated in red), molecular distances between atoms are indicated. C) Model of
5-HT7Egran2 (violet) superposed to 5-HT1B (blue). D) Close view of the ergotamine interaction with some residues of the
transmembrane domains III and V from 5-HT7Egran2. E) Model of 5-HT7Mco1 (Brown) superposed to 5-HT1B (blue). F) Close
view of the ergotamine interaction with some residues of the transmembrane domains III and V from 5-HT7Mco1. In all the
representations, the molecule of ergotamine was marked in green and the residues in transmembrane domains potentially
involved in ergotamine interaction were marked in red.
https://doi.org/10.1371/journal.pntd.0006267.g002
Fig 3. Heterologous expression of GPCRs reveals 5-HT evoked cAMP accumulation. Time resolved measurements of cAMP accumulation in cells expressing
individual cestode serotoninergic GPCRs (A) 5-HT7Egran1, (B) 5-HT7Egran2 and (C) 5-HT7Mco1 before and after addition of IBMX (1
st arrow, 200μM) and different doses of
5-HT (2nd arrow, doses indicated in legend). (D, E & F) dose response relationships to 5-HT measuring peak amplitude of 5-HT evoked luminescence change in cells
expressing the indicated GPCR (solid circles), or untransfected HEK-293 cells (open circles).
https://doi.org/10.1371/journal.pntd.0006267.g003
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an activator of 5-HT7Egran2 (EC50 ~0.8μM) and 5-HT7Mco1 (EC50 ~1μM) but not 5-HT7Egran1
(Fig 4). The first 2 receptors were at least 1000-fold less sensitive to tryptamine than to 5-HT.
Responses to other ligands were considerably smaller, likely representing responses from
endogenous GPCRs in HEK-293 cells (histamine, dopamine) or comparable with levels of
luminescence seen with vehicle control. From this dataset we conclude that each of the cestode
sequences encodes a bona fide serotoninergic GPCR.
Our modelling studies supported an interaction of the ergot alkaloid ergotamine with the
binding pocket of the cestode GPCRs (Fig 2B, 2D & 2F). Therefore we assayed responsiveness
of each GPCR to ergotamine, as well as the synthetic hallucinogen lysergic acid diethylamide
(LSD) which has proved a useful probe ligand for studying 5-HT receptor properties [59].
Ergotamine activated each of the cestode 5HT7Rs but with variable efficacy (Fig 5A, 5B & 5C),
behaving as a low efficacy partial agonist at 5-HT7Egran1 and a higher efficacy partial agonist at
5-HT7Egran2 and 5-HT7Mco1. Each GPCR responded to ergotamine over a similar concentra-
tion range (EC50s of 290±49nM, 234±37nM and 354±62nM for 5-HT7Egran1, 5-HT7Egran2 and
5-HT7Mco1 respectively, Fig 5A, 5B & 5C). Responses to LSD were then examined. Two of the
receptors (5-HT7Egran1 and 5-HT7Mco1) were potently activated by addition of LSD but no
response was observed in cells expressing 5-HT7Egran2 when probed in ‘agonist’ mode (Fig 5D,
5E & 5F). Rather, LSD attenuated the basal coupling of 5-HT7Egran2 and blocked cAMP accu-
mulation in response to a subsequent addition of 5-HT (‘antagonist mode’), demonstrating
LSD acted as an antagonist of 5-HT7Egran2. Full dose response relationships to LSD were per-
formed (Fig 5G, 5H & 5I) which demonstrated EC50s for activation of 35±6nM (5-HT7Egran1)
and 4.4±1.0nM (5-HT7Mco1), and an IC50 for inhibition of 5-HT responses of 2.9±0.2nM
(5-HT7Egran2). Collectively, these functional expression data demonstrate that while each of
these GPCRs is activated by 5-HT, they exhibit distinct pharmacological properties (sensitivity
to 5-HT, differential responsiveness to tryptamine, ergotamine and LSD).
Serotoninergic GPCR expression is localized in particular cellular
territories of E. granulosusprotoscoleces
In order to assess the localization of serotoninergic G-protein coupled receptors in larval stages
of cestodes, we used a fluorescent probe with high affinity for mammalian serotoninergic
GPCRs. Since the first attempts with M. corti tetrathyridia were unsuccessful and owing to the
very limited availability of the probe, we concentrated our efforts in protoscoleces of E. granu-
losus, taking into account the higher size of M. corti tetratyridia compared to E. granulosus pro-
toscoleces. The fluorescent probe—UCM120, a high affinity agonist of the human 5-HT1A
receptor (Ki = 2 nM, Fig 6A) [38]—displayed a distinctive staining pattern in protoscoleces of
E. granulosus. A discontinuous and punctiform pattern of staining could be observed particu-
larly concentrated in suckers but some of this pattern could also be observed in the body (Fig
6B and 6C). Several controls were performed in order to determine the specificity of pattern
observed. When protoscoleces where incubated in the presence of the probe and an excess of
serotonin (1 mM) was added, the staining pattern previously mentioned disappeared (Fig 6D).
The hooks remained strongly stained as seen in controls (Fig 6D), suggesting this represented
non-specific staining or autofluorescence. When protoscoleces where incubated in the pres-
ence of the non fluorescent analog UCM2550, motility was inhibited (Fig 6E, S2 Video). The
dose-response curve obtained with the WMicrotracker device showed a significant fall of
Fig 4. Profiling neurotransmitter specificity against cestode serotoninergic GPCRs. Responses (raw luminescence units,
RLU) in cells transfected with (A) 5-HT7Egran1, (B) 5-HT7Egran2 and (C) 5-HT7Mco1 to indicated neurotransmitters at the
indicated time points in the arrow (10μM), with the exception of 5-HT (700nM in (A), 3nM in (B) and 2nM in (C)).
https://doi.org/10.1371/journal.pntd.0006267.g004
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motility (relative to basal) starting from 100 μM (p< 0.05) until the highest concentration
tested of 1000 μM during a period of two hours (p< 0.05; Fig 6E). However, using a video
based method, lower concentrations produced significant inhibition of motility, starting from
0.1 μM ( P 0.0001; Fig 6F).
Discussion
This work provides for the first time, functional evidence for the existence of serotoninergic
GPCRs in cestodes. Bioinformatic predictions suggesting the presence of several 5-HT-GPCR
Fig 5. Ergot alkaloid activity at cestode 5-HT GPCRs. (A-C) Dose response relationships describing sensitivity and magnitude of peak cAMP accumulation versus
maximal 5-HT response to various doses of ergotamine at (A) 5-HT7Egran1, (B) 5-HT7Egran2 and (C) 5-HT7Mco1 (D-F). Real time kinetic profiling of cAMP accumulation in
response to an addition of either LSD and IBMX (10μM and 200μM, respectively, closed circles) or IBMX alone (200μM, open circles) at first arrow and then subsequent
addition of 5-HT (5 μM, second arrow) for (D) 5-HT7Egran1 or 5-HT (1 μM, second arrow) for (E) 5-HT7Egran2 and (F) 5-HT7Mco1. Dose response relationships for
activation or blockade of 5-HT evoked cAMP accumulation by LSD at (G) 5-HT7Egran1, (H) 5-HT7Egran2 and (I) 5-HT7Mco1.
https://doi.org/10.1371/journal.pntd.0006267.g005
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coding genes were validated by functional studies. From diverse genomic and transcriptomic
databases, several gene models with putative seven transmembrane segments and amino acid
identity with serotoninergic GPCRs were identified in E. granulosus and M. corti. The informa-
tion obtained was used for the cloning of three putative 5-HT GPCRs of cestodes: 5-HT7Egran1,
5-HT7Egran2 and 5-HT7Mco1. The multiple sequence alignment of these clones with serotoniner-
gic and other aminergic GPCRs suggests that the sequences obtained correspond to serotonin-
ergic GPCRs. This result is principally supported by the multiple sequence alignment analysis of
residues potentially involved in ligand binding in transmembrane domain 5. Many aminergic
ligands form critical interactions with residues in TM5, in particular the residues 5.42, 5.43 and
Fig 6. Protoscoleces of Echinococcus granulosus stained with the fluorescent probe UCM120 under the confocal scanning laser microscope and effect of the parent
compound UCM2550 on the motility. - Protoscoleces were fixed, after washing they were incubated in the presence of the probe (100 μM) during several days, washed,
fixed, washed again, mounted, and then observed by confocal microscopy. (A) Structure of the fluorescent probe UCM120 with the structure of the parent compound
UCM2550 shown in black and the dansyl group shown in light brown. Images of two protoscoleces obtained from superficial (B) or from an entire stack of laser scanning
(C). To assess specificity, protoscoleces were labeled under the same conditions with the probe (100 μM) in the presence of an excess (1000 μM) of 5-HT and the image
projection was obtained from an entire stack of pictures (D). Relative motility observed in the presence of increasing concentrations of the parent compound UCM2550 in
the WMicrotracker device measured after two hours of incubation (E); Image based motility quantification measured as a pixel change (F). Further details are provided in
the Methods section. Asterisks indicate treatments found to be significantly different from the controls (P 0.05) with t-test (E) or ANOVA and Dunnet post
comparison tests (P 0.0001, F). R: rostellum; S: suckers and Bo: body. The scale bar represents 50 μm in (A), (B) and (C) and 100 μm in (D). Arrowheads indicate
localization of the probe.
https://doi.org/10.1371/journal.pntd.0006267.g006
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5.46 [60, 62]. These residues can be used to discriminate between serotoninergic and other ami-
nergic GPCRs and much of the specificity of GPCRs could be attributable to TM5 properties
[68]. The crucial residues 5.42 and 5.46 are generally conserved in mammalian serotonin recep-
tors, particularly in subtypes 1 (5-HT1) and 7 (5-HT7). It was reported that those residues are
usually less polar in serotoninergic (no more than one polar residue) than the corresponding
residues of adrenergic, dopaminergic and histaminergic receptors [62]. The substitution of the
polar serine by the non polar alanine at position 5.42 observed here in cestode 5HT-GPCRs was
reported before in some invertebrate receptors, for example in D. japonica [15] and S. mansoni
[18]. Indeed, the residues “AA” in the position 5.42 and 5.46 respectively in planarian receptors
were proposed as diagnostic for assignment to the clade 7 of the invertebrate receptors [15].
The threonine residue in position 5.43 is also conserved in cestode and trematode sequences as
it was in mammalian receptors. In addition, several motifs commonly found in aminergic
receptors, that could be critical for receptor function, were also found in the cestode sequences.
Phylogenetic analysis showed a close relationship between the cloned cestode receptors and
the clade 7 according to the invertebrate classification. These subtype of receptors are coupled
to Gs predicting an increase of cAMP levels upon stimulation. Consistent with the bioinfor-
matic prediction, all the cloned cestode receptors produced high levels of cAMP upon incuba-
tion with 5-HT.
The cestode 5-HT GPCRs were found to be expressed in motile life cycle stages such as pro-
toscolex and adult worms, as well as in the hydatid cyst, suggesting that those receptors could
have other activities besides motor control.
The molecular modeling of the cloned receptors and the comparison with the mammalian
counterpart showed a striking resemblance at the structural level, in coincidence with the
results obtained by multiple sequence alignment. The position of the orthosteric binding
pocket and the docking with ergotamine are in line with these structural similarities.
In agreement with bioinformatic predictions, the increase in larval motility upon incuba-
tion with serotonin suggests the presence of serotoninergic receptors. In concordance with
previous work [3], the addition of serotonin to M. corti tetrathyridia caused a significant stim-
ulation of motility in a dose response fashion. Previously, we have shown that E. granulosus
protoscoleces responded to serotonin [16] using the same method. The stimulation of M. corti
tetrathyridia motility exerted by serotonin was observed with higher concentrations (starting
from 500 μM during 30 minutes of incubation, using a light scattering method) than those pre-
viously reported (100 nM, during 30 minutes of incubation) [3] and this could be attributed to
differences in the biological samples used and/or the different sensitivity of the equipment
employed in both cases. Other factors such as preincubation time and medium could also con-
tribute to the differences observed. We were unable, by using imaging techniques, to find a sig-
nificant stimulation of motility below 1000 μM of serotonin after 30 minutes of incubation
with the drug. The increase on motility obtained in the presence of this neurotransmitter was
observed until 60 minutes, but later the activity tended to fall. This could be due to an inactiva-
tion process after overstimulation of serotoninergic receptors [61].
In order to confirm the bioinformatic and the phylogenetic predictions, we heterologously
expressed the cloned sequences and analyzed the intracellular response to receptor ligands.
Remarkably, the three cloned sequences yielded elevated levels of cAMP accumulation upon
incubation with serotonin. This response was not observed with other neurotransmitters.
Interestingly, for two of the cloned receptors the EC50 was in the picomolar range. To the best
of our knowledge, this is the lowest EC50 value reported for 5-HT GPCRs and would identify
them as the most sensitive 5-HT receptors reported in any invertebrate. Differences between
the three cloned receptors were also observed in their responses to three tested ligands: trypt-
amine was an activator of 5-HT7Egran2 and 5-HT7Mco1 but not 5-HT7Egran1; ergotamine activated
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the three GPCRs with variable efficacy, behaving as a low efficacy partial agonist at 5-HT7Egran1
and a higher efficacy partial agonist at 5-HT7Egran2 and 5-HT7Mco1; the hallucinogen LSD was a
potent agonist [69] of 5-HT7Egran1 and 5-HT7Mco1 but an antagonist at 5-HT7Egran2. This differ-
ential response to LSD could be related to the divergence of 5-HT7Egran2 from 5-HT7Egran1 and
5-HT7Mco1 as seen in the multiple sequence alignment and phylogeny (Fig 1).
The EC50 for 5-HT in 5-HT receptors from invertebrates [18, 70, 71], as well as from the
vertebrate host [72], show values in the nM to μM interval. Unexpectedly, the receptors cloned
showed distinct pharmacological properties characterized by an extremely high sensitivity
(picomolar EC50 value) to 5-HT in 5-HT7Egran2 and 5-HT7Mco1. Another remarkable difference
with other receptors was that the allucinogen LSD, which has an agonist activity in several
5-HT7 receptors from invertebrates [73–76] and vertebrates [69], behaved as an antagonist in
the 5-HT7Egran2 receptor. The unique properties of these highly expressed tapeworm receptors
may be exploitable for drug design.
Another noteworthy discovery was a high level of basal coupling observed for two of the
GPCRs, which could relate to their high affinity for serotonin (picomolar EC50 values). Basal
coupling may have resulted from the presence of low levels of contaminating 5-HT in media
in the face of the high receptor affinity for 5-HT. Alternatively, basal activity may represent
constitutive activity of these receptors. There are several examples of constitutive activity in
GPCRs of diverse ligand specificity [77], including serotoninergic GPCRs from vertebrates
[78] and invertebrates [79]. The physiological significance of this basal coupling activity–if
manifest outside the heterologous assays system used here—is not clear but constitutive activ-
ity of these GPCRs may provide tonic support for basal neuromuscular activity [77].
There is clear discordance between the concentration of serotonin needed to activate the
receptors heterologously expressed in vitro (picomolar-nanomolar range) and the concentration
to induce motility in vivo (micromolar range) in larval stages of cestodes. There are several char-
acteristics of each assay system which could explain this difference. For example, in the in vitro
system a high density of receptors are directly exposed to the media, while in vivo endogenous
levels of receptors will be localized within internal compartments of the parasite. Rapid uptake
of serotonin by endogenous cells could also contribute to the low potency of 5-HT on intact
worms. Differences in receptor environment may also play a role, including interacting proteins
such as G proteins with different affinities for these receptors in both systems. Finally, in the
whole parasite several receptors subtypes are probably activated at the same time: some recep-
tors will stimulate the cAMP generation by Gs coupling (e.g. 5-HT7Egran1 and 5-HT7Egran2 in
Echinococcus granulosus) while others may decrease cAMP through Gi coupling [for example,
receptors encoded by gene models ECANG7_00799 (named as 5-HT1Ecan1 in Fig 1) and
ECANG7_02049 (named as 5-HT1Ecan2 in Fig 1) are yet to be characterized].
The fluorescent images obtained showed a particular pattern of punctiform and discontinu-
ous staining concentrated in the suckers of the protocolex, structures involved in parasite
attachment to the host intestine. The addition of excess 5-HT caused the disappearance of this
signal and moreover, the addition of the analogous UCM2550 to protoscoleces in motility
experiments, resulted in inhibition of motility supporting the results obtained by imaging
methods. In this case, serotonin could be exerting its effects through serotoninergic receptors
located at the surface of the protoscolex (particularly at the suckers) and in this way the para-
site could sense the serotonin from the host.
Neuroactive substances such as serotonin could play a leading role not only at neuromuscu-
lar control but also in development and reproduction in flatworms [5, 80] and other inverte-
brates [81]. The precise role played by serotonin at the neuromuscular junction in flatworms is
still unknown. In other invertebrates, for example at the crustacean neuromuscular junction, it
was shown that the application of 5-HT increases the total synaptic pool size of releasable
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synaptic vesicles in response to an action potential in the presynaptic terminal [82]. Moreover,
it was shown in the same system that 5-HT accelerates the kinetics with which the transmitter
is released and increase the total amount of transmitter released [83]. Perhaps, it could be
hypothesized that a similar mechanism of action could be operating in a similar way at neuro-
muscular junctions in cestodes after 5-HT addition but more experiments are needed to test
this hypothesis. In E. granulosus it was found that serotonin could have a major role in devel-
opment [16]. However, the potential role played in development by the GPCRs described here
is at present unknown. The innervation of reproductive structures by the serotoninergic nerve
elements could be also of major importance for parasite propagation [5]. In E. granulosus, the
genital atrium and associated reproductive ducts are richly innervated with serotoninergic
nerve cells bodies and nerve fibres [84]. For all these reasons, targeting the serotoninergic
structures of the parasite will convey potential benefits beyond the essential function of para-
site attachment: development and reproduction could also be impaired. Considering the par-
ticular sensitivity to 5-HT and their different pharmacology, we view the serotoninergic
GPCRs described here are promising drug targets for Echinococcus spp. A more detailed char-
acterization of the response of the receptors cloned here to other known serotoninergic ligands
will advance our structural understanding of these binding sites to allow identification of selec-
tive cestode 5HT receptor antagonists.
Cloning and successful heterologous expression of these GPCRs now permits the possibility
of high throughput screening campaign for the first time. The development of more specific
agents against the parasitic over the mammalian host could deliver novel drugs for treatment
of hydatid disease.
In conclusion, we have identified for the first time several genes encoding for serotoninergic
G-protein coupled receptors from cestodes based on: i) seven transmembrane domains and
conserved motifs commonly found on this kind of receptors, ii) striking structural similarity
found by homology modeling, iii) high levels of cAMP accumulation in functional studies
after heterologous expression of cDNAs in HEK-293 cells showing overall agreement with in
vitro responses of parasites to serotonin and 5-HT GPCR ligands. The cloned receptors
showed distinct pharmacological properties with differential sensitivity to 5-HT and differen-
tial responsiveness to tested ligands. As these genes are expressed in clinically relevant parasite
stages, these GPCRs merit evaluation as novel targets for chemotherapy to combat neglected
diseases caused by cestodes.
Supporting information
S1 Table. Primers used for serotoninergic GPCR cloning and first strand cDNA synthesis.
(DOCX)
S1 Text. Nucleotide and amino acid sequences of cloned 5-HT7Egran1, 5-HT7Egran2 and
5-HT7Mco1 cestode 5-HT receptors.
(DOCX)
S1 Fig. Ramachandran plots of the three modeled G-protein coupled receptors from ces-
todes. General, glycine, pre-pro and proline plots of the models for: A) 5-HT7Egran1, B)
5-HT7Egran2 and C) 5-HT7Mco1. The difference between favored and allowed regions are
indicated by the color intensity. Residues are indicated in blue (general, pre-pro), brown (gly-
cine) and green (proline). Residues in outlier regions are indicated in white.
(TIF)
S2 Fig. Diagram of the imaging technique used for protoscolex and tetrathyridium motil-
ity quantification. Major steps in the processing of video images are shown. Further details
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are provided in the material and methods section.
(TIF)
S3 Fig. Multiple sequence alignment of serotoninergic G-protein coupled receptors with
Echinococcus granulosus and Mesocestoides cortiGPCRs. A Multalin alignment was performed
using the three amino acid sequences encoding for 5-HT GPCRs of cestodes (5-HT7Egran1,
5-HT7Egran2 and 5-HT7Mco1) cloned in this work and representative examples of vertebrate and
invertebrate serotoninergic GPCRs: Human 5-HT1B receptor (5HT1bHs, NP_000854.1) and
5-HT7 receptor (5-HT7Hs, P34969.2); Caenorhabditis elegans ser-4 (CeleSER_4, NP_497452.1)
and ser-7 (CeleSER_7, NP_741730.1); Schistosoma mansoni 5-HT7Sm receptor (ANG84010.1).
Amino acid residues which are identical in all the aligned sequences are shown in white on black
background, residues identical in at least six of the aligned sequences are shown in white on dark
gray background, and finally, residues identical in five of the aligned sequences are shown black
on light gray background. Transmembrane domains (TM1–TM7) are shown as thick lines above
the alignment and extracellular (EL) or intracellular (IL) loops are indicated. The most important
residues involved in ligand recognition or receptor function were indicated inside boxes. The sim-
bols C1 and C2 marked in bold inside boxes, refers to residues V155 and L6.37 respectively,
potentially important for coupling with G-proteins. Conserved motifs were also indicated below
the alignment.
(TIF)
S4 Fig. Multiple sequence alignment of the fifth transmembrane segment of cloned cestode
serotoninergic GPCRs with other members of the rhodopsin family of GPCRs. The multiple
sequence alignment of the fifth transmembrane segment of 5-HT7Egran1 with other GPCRs is
shown in A). In B), the same alignment is shown but the cestode sequence shown in A) was
replaced with 5-HT7Egran2 and finally, in C) the cestode sequence of 5-HT7Mco1 was used
instead. Transmembrane domain five (TM5) is shown as a thick line above the alignment.
Amino acid residues which are identical in all the aligned sequences are printed in white on
black background, residues identical in at least seven of the aligned sequences are printed in
white on gray background, and finally, residues identical in at least five of the aligned sequences
are printed black on gray background. Residues important for function were underlined and
indicated by an arrow below the alignment. The sequences used for each alignment were
(with accession numbers in parenthesis): Sm5HTR from Schistosoma mansoni (ANG84010.1)
and the rest of the sequences were from Homo sapiens: 5HT1B_HUMA, 5-HT1B receptor
(NP_000854.1); 5HT2A_HUMA, 5-HT2A receptor (P28223); 5HT7R_HUMA, 5-HT7 receptor
(P34969); ADA1A_HUMA, Alpha-1A adrenergic receptor (P35348); D2_HUMAN, Dopamine
receptor D2 (A0A024R3C5); ACM1_HUMAN, Muscarinic acetylcholine receptor M1 (P11229)
and HRH1_HUMAN, Histamine H1 receptor (P35367).
(TIF)
S5 Fig. Gene expression levels of two serotoninergic GPCRs. Levels of expression (in
RPKM) of 5-HT7Egran1 and 5-HT7Egran2 serotoninergic GPCRs in the oncosphere, cyst, proto-
scolex and adult stage of Echinococcus granulosus.
(TIF)
S6 Fig. Serotonin (5-HT) stimulates the neuromuscular activity of the tetrathyridium of
Mesocestoides corti. A) Channel activity traces from the WMicrotracker device before (Basal)
and after the addition of 2000 μM of serotonin (5-HT 2000 μM) during a period of two hours.
B) Relative motility counts without (0 μM, white bar) or after the addition of increasing con-
centrations of serotonin during a period of two hours. C) Relative motility counts after the
addition of the same concentrations of serotonin as in B), but accumulated during a period of
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30 minutes and during the intervals of 0–30 (30), 30–60 (60), 60–90 (90) and 90–120 (120)
minutes after the addition of 5-HT. D) Relative motility without (0 μM, white bar) or after the
addition of increasing concentrations of serotonin during a period of 30 minutes by video
imaging. ANOVA and Dunnet post comparison tests were performed. Asterisks indicate treat-
ments found to be significantly different from the controls (P 0.05, P 0.01 and
P 0.001). Most of the experiments were performed using 16 technical replicates per treat-
ment condition and repeated with four different biological samples with the exception of the
experiment showed in D, in which eight technical replicates and repeated with three different
biological samples.
(TIF)
S1 Video. Video images of the Mesocestoides corti tetrathyridium in RPMI medium alone
(control) or with 1000 μM of serotonin in RPMI. Further details are provided in the Methods
section.
(MOV)
S2 Video. Video images of Echinococcus granulosus protoscoleces in RPMI medium alone
(control) or with 100 μM of UCM2550 in RPMI. Further details are provided in the Methods
section.
(MOV)
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